Pharmaceutical shortages items; including, but not limited to, blood products such as: carimune; oncological pharmaceuticals such as: vinblastine, novoseven and other relevant pharmaceuticals products…
Ended Awarded
- Contract number
- HT001417F0115
- Awardee
-
TDS Med, Inc. UEI L8RFE2B8JCK4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $150,000
Award facts
- Contract value 100% obligated
- $150,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is a Blanket Purchase Agreement (BPA) call issued by the Defense Health Agency to the prime contractor TDS Med, Inc., a self-certified small disadvantaged business. The $150,000 firm fixed-price contract is to provide pharmaceutical products including blood products, oncological pharmaceuticals, injectables, orals, and medical inhalations to address shortages. The contract has a completion date of September 30, 2017. TDS Med, Inc. holds an active $2 million BPA with the Defense Health Agency that runs through September 2024, under which task orders are issued to fulfill requirements related to shortage pharmaceuticals. TDS Med, Inc. has previously provided pharmaceutical products and supplies, including for COVID-19 response efforts, to federal agencies such as the Department of the Air Force and the Department of Justice Bureau of Prisons.
Description
Pharmaceutical shortages items; including, but not limited to, blood products such as: carimune; oncological pharmaceuticals such as: vinblastine, novoseven and other relevant pharmaceuticals products including injectables, orals and medicinal inhalations.
Quick answers
Who was awarded contract HT001417F0115?
HT001417F0115 was awarded to TDS Med, Inc. by Defense Health Agency (Department of Defense) on June 12, 2017.
How much is contract HT001417F0115 worth?
The government has obligated $150,000 on HT001417F0115.
Is contract HT001417F0115 an order under another contract?
Yes. HT001417F0115 is a BPA call under HT001414A0004, a blanket purchase agreement.
Was contract HT001417F0115 competed?
The extent of competition for HT001417F0115 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award